Ahmed AU - Search Results

1

FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis.

Cordero A, Kanojia D, Miska J, Panek WK, Xiao A, Han Y, Bonamici N, Zhou W, Xiao T, Wu M, Ahmed AU, Lesniak MS. Cordero A, et al. Among authors: ahmed au. Oncogene. 2019 Sep;38(37):6445-6460. doi: 10.1038/s41388-019-0893-4. Epub 2019 Jul 19. Oncogene. 2019. PMID: 31324889 Free PMC article.

2

Crossing the boundaries: stem cells and gene therapy.

Ferguson SD, Ahmed AU, Thaci B, Mercer RW, Lesniak MS. Ferguson SD, et al. Among authors: ahmed au. Discov Med. 2010 Mar;9(46):192-6. Discov Med. 2010. PMID: 20350484 Free PMC article. Review.

3

Bone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat model.

Ahmed AU, Rolle CE, Tyler MA, Han Y, Sengupta S, Wainwright DA, Balyasnikova IV, Ulasov IV, Lesniak MS. Ahmed AU, et al. Mol Ther. 2010 Oct;18(10):1846-56. doi: 10.1038/mt.2010.131. Epub 2010 Jun 29. Mol Ther. 2010. PMID: 20588259 Free PMC article.

4

The use of neural stem cells in cancer gene therapy: predicting the path to the clinic.

Ahmed AU, Alexiades NG, Lesniak MS. Ahmed AU, et al. Curr Opin Mol Ther. 2010 Oct;12(5):546-52. Curr Opin Mol Ther. 2010. PMID: 20886386 Free PMC article. Review.

5

Enhanced transduction and replication of RGD-fiber modified adenovirus in primary T cells.

Sengupta S, Ulasov IV, Thaci B, Ahmed AU, Lesniak MS. Sengupta S, et al. Among authors: ahmed au. PLoS One. 2011 Mar 28;6(3):e18091. doi: 10.1371/journal.pone.0018091. PLoS One. 2011. PMID: 21464908 Free PMC article.

6

Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.

Ahmed AU, Thaci B, Alexiades NG, Han Y, Qian S, Liu F, Balyasnikova IV, Ulasov IY, Aboody KS, Lesniak MS. Ahmed AU, et al. Mol Ther. 2011 Sep;19(9):1714-26. doi: 10.1038/mt.2011.100. Epub 2011 May 31. Mol Ther. 2011. PMID: 21629227 Free PMC article.

7

Glioblastoma multiforme: can neural stem cells deliver the therapeutic payload and fulfill the clinical promise?

Ahmed AU, Lesniak MS. Ahmed AU, et al. Expert Rev Neurother. 2011 Jun;11(6):775-7. doi: 10.1586/ern.11.65. Expert Rev Neurother. 2011. PMID: 21651324 Review. No abstract available.

8

A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.

Ahmed AU, Tyler MA, Thaci B, Alexiades NG, Han Y, Ulasov IV, Lesniak MS. Ahmed AU, et al. Mol Pharm. 2011 Oct 3;8(5):1559-72. doi: 10.1021/mp200161f. Epub 2011 Jun 30. Mol Pharm. 2011. PMID: 21718006 Free PMC article.

9

Maintaining and loading neural stem cells for delivery of oncolytic adenovirus to brain tumors.

Ahmed AU, Ulasov IV, Mercer RW, Lesniak MS. Ahmed AU, et al. Methods Mol Biol. 2012;797:97-109. doi: 10.1007/978-1-61779-340-0_8. Methods Mol Biol. 2012. PMID: 21948472 Review.

10

Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.

Thaci B, Ahmed AU, Ulasov IV, Tobias AL, Han Y, Aboody KS, Lesniak MS. Thaci B, et al. Among authors: ahmed au. Cancer Gene Ther. 2012 Jun;19(6):431-42. doi: 10.1038/cgt.2012.21. Epub 2012 May 4. Cancer Gene Ther. 2012. PMID: 22555507 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters